Induction of Neoplasia After Deep Anterior Lamellar Keratoplasty in a CXL-Treated Cornea

PURPOSE:Corneal collagen crosslinking (CXL) with ultraviolet-A energy plus riboflavin has become a ubiquitous treatment in early keratoconus, although its long-term safety is unknown. We describe severe sequelae in a CXL-treated patient after he underwent a standard deep anterior lamellar keratoplas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cornea 2014-03, Vol.33 (3), p.313-316
Hauptverfasser:	Krumeich, Jörg H, Brand-Saberi, Beate, Chankiewitz, Verena, Chankiewitz, Erik, Guthoff, Rudolf
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma in Situ - diagnosis Carcinoma in Situ - etiology Collagen - metabolism Conjunctival Neoplasms - diagnosis Conjunctival Neoplasms - etiology Corneal Stroma - metabolism Corneal Transplantation - adverse effects Cross-Linking Reagents - therapeutic use Humans Keratoconus - drug therapy Keratoconus - metabolism Male Middle Aged Photosensitizing Agents - therapeutic use Riboflavin - therapeutic use Ultraviolet Rays Visual Acuity - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!